Flow Diverters Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

Flow diverters represent a specialized segment within the neurovascular devices market, primarily used to treat wide-necked and complex intracranial aneurysms that are difficult to address with traditional coiling or clipping methods. The global market reached approximately $0.6 billion in 2025, with continued expansion expected as clinical evidence supporting flow diversion therapy accumulates. These devices are typically deployed via catheter-based procedures, offering a less invasive alternative to open surgical approaches.

• •Used primarily for unruptured intracranial aneurysm treatment, particularly wide-necked and fusiform types
• •Procedures performed via femoral or radial artery access under fluoroscopic guidance
• •Requirement for dual antiplatelet therapy post-placement influences patient selection and clinical protocols

The aging global population contributes to higher prevalence of intracranial aneurysms, while advances in imaging and interventional techniques expand the treatable patient pool. Increasing awareness of minimally invasive options among both physicians and patients is shifting treatment preferences away from open surgical clipping. Additionally, favorable clinical trial data demonstrating safety and efficacy profiles continues to support broader adoption across hospital neurovascular programs.

• •Rising incidence of cerebrovascular diseases and improved diagnostic imaging rates
• •Growing preference for endovascular over open surgical interventions among neurosurgeons
• •Expansion of treatment indications and accumulating long-term clinical evidence supporting device performance

The market is segmented by device type, including standard flow diverters, flow-diverter stents, and modified surface-treated variants designed to reduce thrombogenicity. Geographically, North America leads due to advanced healthcare infrastructure and high procedural volumes, while Europe represents a significant share driven by established neurovascular networks. The Asia-Pacific region is emerging as the fastest-growing market, supported by rising healthcare investments, improving hospital capabilities, and growing disease awareness.

• •North America accounts for the largest regional share, followed by Europe and Asia-Pacific
• •Emerging markets in Latin America and the Middle East are gradually adopting flow diversion technology
• •Hospital-based neurovascular centers and ambulatory surgical centers represent key distribution channels

What are the recent trends and outlook?

Future growth will be supported by ongoing device innovation, including lower-profile delivery systems, surface modifications to reduce platelet activation, and designs optimized for specific vessel anatomies. Value-based healthcare models are encouraging outcomes-driven adoption, potentially accelerating uptake in health systems that have been slower to embrace the technology. The market's 13.2% annual growth trajectory suggests continued expansion through the early 2030s as new entrants introduce competitive products and as device accessibility improves in developing regions.

• •Next-generation devices featuring thinner struts and improved trackability for challenging anatomies
• •Research into flow diverters for ruptured aneurysm treatment and pediatric applications
• •Increasing shift toward hospital procurement collaborations and bundled payment arrangements